Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
Figure 5
(a) Comparison of tender joint count between iguratimod and placebo groups. (b) Comparison of tender joint count between iguratimod and other DMARDs (MTX and SASP) groups.
